New Year CPhI Japan report predicts 2018 will be a transformative year for Japanese pharma, with early movers likely to benefit. A New Year report from CPhI forecasts 2018 will be a transformative year for Japanese pharma as the market evolves towards growth in generics, biosimilars, and increased internationalization. The CPhI Japan 2018 report — released ahead…
India Manufacturers Expected to Make Acquisitions & Invest in Continuous Manufacturing in Coming Years
CPhI India Report identifies two-tier manufacturing market and predicts increased acquisitions. CPhI released findings from the 2017 India Pharma Market Report, which identified a two-tier manufacturing market and forecast increased acquisitions by Indian companies, along with a notable improvement in the international reputation of Indian made pharmaceuticals. But perhaps most dramatically, a large majority of domestic…
CPhI Worldwide Experts Predict CDMO Mega-Mergers and Chinese Patented Products Imminent
CPhI Worldwide, (#cphiww) organized by UBM EMEA, announces the findings of part ii of the 2016 CPhI Annual Report, which focuses on the immediate and short-term trends in pharmaceutical outsourcing. Four experts—Gil Roth, Vivek Sharma, Dr. Minzhang Chen, and Ravi Limaye—examine the implications on growth prospects and drag factors across the EU, China, India, and…